{"slug":"tesamorelin-cognition","verification":{"valid":true,"entries":2,"head":"5a0a6854a053ed1c99bffd4f57d57405c6faf86f241c0069b3adbc206cc281b9"},"energy":{"passes":2,"tokens_in":32009,"tokens_out":2538,"tokens_total":34547,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5a0a6854a053ed1c99bffd4f57d57405c6faf86f241c0069b3adbc206cc281b9"},"provenance":[{"ts":"2026-06-29T23:24:58.524Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Cognition\nSlug: tesamorelin-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down\",\"Why Tesamorelin might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide ","response":"{\"slug\":\"tesamorelin-cognition\",\"title\":\"Tesamorelin for Cognition: Human Trial Data and Evidence Layers\",\"body\":\"## What's breaking down\\n\\nCognitive function can decline with age through reduced growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signaling. Visceral fat accumulation adds inflammatory load that may impair brain insulin sensitivity and hippocampal performance. These layers compound: lower GH axis activity limits tissue repair signals while excess abdominal fat sustains low-grade inflammation that affects executive function and memory. Tesamorelin is discussed here because it stimulates endogenous GH release, a pathway tied to both visceral fat reduction and potential brain repair signals, rather than symptom masking.\\n\\n## Why Tesamorelin might help you\\n\\nIf declining GH/IGF-1 signaling and visceral fat contribute to your cognitive profile, Tesamorelin targets the GH axis directly.\\n\\n1. Tesamorelin binds GHRH receptors in the pituitary.\\n2. This raises pulsatile GH output and circulating IGF-1 within physiological ranges.\\n3. Elevated IGF-1 supports neuronal maintenance and may improve executive function measures.\\n4. Parallel visceral fat reduction lowers inflammatory signals that can blunt brain insulin response.\\n\\nTherefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tesamorelin addresses the GH axis / visceral fat layer. Any multi-peptide stack would map additional degeneration layers separately.\\n\\n## What the evidence actually shows\\n\\nOne randomized, double-blind, placebo-controlled human trial (152 adults, mean age 68, 20 weeks, 1 mg daily tesamorelin or placebo) found favorable effects on cognition overall (intent-to-treat P = .03). Executive function improved (P = .005). Verbal memory showed a trend (P = .08). Effects appeared in both healthy older adults and those with mild cogniti","tokens_in":32009,"tokens_out":2538,"cost":0,"prev":"genesis","hash":"0aba422b0428af32ab741398f37aa8f83deb7f26dc1630660be3ff700cf79eaa"},{"ts":"2026-07-17T02:42:21.468Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-cognition","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0aba422b0428af32ab741398f37aa8f83deb7f26dc1630660be3ff700cf79eaa","hash":"5a0a6854a053ed1c99bffd4f57d57405c6faf86f241c0069b3adbc206cc281b9"}]}